Skip to main content

Table 2 Pathway mapping of TQ-phosphorylated targets by Annotation cluster3

From: Thymoquinone-induced conformational changes of PAK1 interrupt prosurvival MEK-ERK signaling in colorectal cancer

Database

Pathway

p-Value

Genes identified by peptide array

KEGG_PATHWAY

T cell receptor signaling pathway

0.001971

PDK1, AKT1, RAF1, PAK1*, MAP3K7

PANTHER_PATHWAY

Angiogenesis

0.008722

AKT1, TCF7L2, APC, RAF1, PAK1, CTNNB1, NOS1

KEGG_PATHWAY

MAPK signaling pathway

0.041478

MAX, AKT1, RAF1, PAK1, MAP3K7

KEGG_PATHWAY

Chemokine signaling pathway

0.042726

AKT1, CCR2, RAF1, PAK1

KEGG_PATHWAY

Renal cell carcinoma

0.053539

AKT1, RAF1, PAK1

PANTHER_PATHWAY

Ras Pathway

0.054889

AKT1, RAF1, PAK1, MAP3K7

BIOCARTA

Influence of Ras and Rho proteins on G1 to S Transition

0.055681

AKT1, RAF1, PAK1

KEGG_PATHWAY

ErbB signaling pathway

0.079412

AKT1, RAF1, PAK1

KEGG_PATHWAY

Focal adhesion

0.091138

AKT1, RAF1, PAK1, CTNNB1

KEGG_PATHWAY

Fc gamma R-mediated phagocytosis

0.093575

AKT1, RAF1, PAK1

BIOCARTA

MAPKinase Signaling Pathway

0.094598

MAX, RAF1, PAK1, MAP3K7

PANTHER_PATHWAY

Inflammation mediated by chemokine and cytokine signaling pathway

0.229979

AKT1, CCR2, RAF1, PAK1, MAP3K7

PANTHER_PATHWAY

T cell activation

0.27141

AKT1, RAF1, PAK1

  1. *PAK1 is given in bold letters.